Pages that link to "Q44915015"
Jump to navigation
Jump to search
The following pages link to Inhaled zanamivir versus rimantadine for the control of influenza in a highly vaccinated long-term care population. (Q44915015):
Displaying 14 items.
- Systematic review of influenza resistance to the neuraminidase inhibitors (Q21261835) (← links)
- Amantadine and rimantadine for influenza A in children and the elderly (Q24187883) (← links)
- Amantadine and rimantadine for influenza A in children and the elderly (Q24203853) (← links)
- Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children (Q24203905) (← links)
- Amantadine and rimantadine for influenza A in children and the elderly (Q24242639) (← links)
- Optimal design of intervention studies to prevent influenza in healthy cohorts (Q28730583) (← links)
- Antiviral management of seasonal and pandemic influenza. (Q30358735) (← links)
- A systematic mapping review of randomized controlled trials (RCTs) in care homes (Q34316513) (← links)
- Restoring invisible and abandoned trials: a call for people to publish the findings (Q36937327) (← links)
- Complications of viral influenza (Q37122305) (← links)
- Zanamivir for the prevention of influenza in adults and children age 5 years and older. (Q37167230) (← links)
- Influenza in the elderly: a mini-review (Q37784118) (← links)
- Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America (Q48585293) (← links)
- Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa (Q64134362) (← links)